Anti-ApoE Polyclonal Antibody

品牌：solarbio | 货号：K001672P

商品货号：	商品品牌：	规格	基本售价：	选择规格
K001672P-50ul	solarbio	50ul	960.00元
K001672P-100ul	solarbio	100ul	1600.00元

英文名称 Anti-ApoE Polyclonal Antibody
别名 AD2;APO-E;ApoE4;LDLCQ5;LPG
应用 WB IHC IF
稀释比例 WB 1:1000-3000.IHC 1:50-200. IF 1:50-100.
交叉反应 Human Mouse
蛋白分子量 36kDa
Gene ID 348
保存 Store at -20°C. Avoid freeze / thaw cycles.
储存液 Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
纯化方法 Affinity purification
亚型 IgG
免疫原 A synthetic peptide of human ApoE
性状 液体
Public Immunogen Range A synthetic peptide of human ApoE
Subcellular Locations Secreted
Swiss Prot P02649
克隆类型 Polyclonal Antibody
背景资料 The protein encoded by this gene is a major apoprotein of the chylomicron. It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. This gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes. Mutations in this gene result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants.

英文名称	Anti-ApoE Polyclonal Antibody
别名	AD2;APO-E;ApoE4;LDLCQ5;LPG
应用	WB IHC IF
稀释比例	WB 1:1000-3000.IHC 1:50-200. IF 1:50-100.
交叉反应	Human Mouse
蛋白分子量	36kDa
Gene ID	348
保存	Store at -20°C. Avoid freeze / thaw cycles.
储存液	Buffer: PBS with 0.02% sodium azide, 50% glycerol, pH7.3.
纯化方法	Affinity purification
亚型	IgG
免疫原	A synthetic peptide of human ApoE
性状	液体
Public Immunogen Range	A synthetic peptide of human ApoE
Subcellular Locations	Secreted
Swiss Prot	P02649
克隆类型	Polyclonal Antibody
背景资料	The protein encoded by this gene is a major apoprotein of the chylomicron. It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. This gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes. Mutations in this gene result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants.